Fundraising Fox

Octant Bio

Emeryville, US · 10 known investors

octant.bio ↗

Octant is a therapeutics company that develops small molecule drugs to treat protein misfolding diseases. Using synthetic biology, high-throughput chemistry, and AI/ML, the company's Navigator platform studies how target proteins interact within living human cells to enable drug discovery for rare diseases and oncology.

AI & Machine LearningBiotechDeep TechMedical Devicesin /octantbio@OctantBio

Founders & leadership

SK
Sri KosuriinCo-founder

Investors · 10

Andreessen Horowitz✓ verifiedMenlo Park · $500K – $50M
+ND CapitalWoodside · $540K – $5.4M
8VCAustin · $100K – $50M
Carbon SiliconCarson City · $100K – $500Kvia Nish Bhat · inferred
Catalio Capital Management, LPNew York
Fifty YearsSan Francisco · $250K – $2M
Flucas VenturesJupiter · $100K – $5Mvia Ashley Flucas · inferred
MetaplanetTallinn · $500K – $10M
Ulu VenturesPalo Alto · $2M
Refactor CapitalreportedBurlingame · $1M – $2M

In the news